Answers are grounded in this paper and cite their sources.
Evaluates anti-mycobacterial activity of triazole derivatives, revealing limited efficacy against tuberculosis.
Click chemistry, exemplified by the copper-catalyzed azide-alkyne cycloaddition (CuAAC), is a pivotal technique in modern synthetic chemistry for its efficiency, selectivity, and mild reaction conditions. This method is forming 1,2,3-triazole rings from azides and alkynes, thus aiding in the synthesis of complex molecules. In this study, we exploit CuAAC to synthesize and characterize 2-oxo-1-((1-phenyl-1H-1,2,3-triazol-4-yl)methyl)-1,2-dihydroquinoline-3-carbaldehyde derivatives (7a–7t). These compounds were synthesized by reacting quinoline-based precursors with azidobenzene derivatives in the presence of a copper catalyst. We meticulously optimized reaction conditions, leading to a maximum yield of 96% using a solvent system of DMF, t-butanol, and water. The synthesized compounds were evaluated for anti-mycobacterial activity against Mycobacterium tuberculosis. Although Rifampicin, a known anti-mycobacterial agent, exhibited exceptional efficacy, the majority of the 2-oxo-1-((1-phenyl-1H-1,2,3-triazol-4-yl)methyl)-1,2-dihydroquinoline-3-carbaldehyde derivatives (7a–7t) showed limited or no significant activity. This study highlights both the potential of CuAAC in generating novel compounds and the challenges faced in developing effective anti-mycobacterial agents.
No takes yet. Share an insight, caveat, or question.
Manvar et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: